↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over

e.g. Sirolimus, アダリムマブ

ABCDEFGH I JKLMNOPQRSTUVWXYZother

13 / 17,542 descriptions

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes		 指定難病告示番号
1 Abp 959 - biosimilar to eculizumab Eculizumab 1件: D03940 💬 1件: C5 💬 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 1件: 62 💬
2 Abp 959 - proposed biosimilar to eculizumab Eculizumab 1件: D03940 💬 1件: C5 💬 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 1件: 62 💬
3 Eculizumab Eculizumab 1件: D03940 💬 1件: C5 💬 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 8件: 11, 13, 14, 61, 62, 109, 222, 223 💬
4 Other: blood collection for measurement of eculizumab peak concentrations Eculizumab 1件: D03940 💬 1件: C5 💬 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 1件: 62 💬
5 Other: eculizumab Eculizumab 1件: D03940 💬 1件: C5 💬 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 1件: 109 💬
6 Sb12 (proposed eculizumab biosimilar) Eculizumab 1件: D03940 💬 1件: C5 💬 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 1件: 62 💬
7 Soliris - - - - 7件: 11, 13, 14, 61, 62, 109, 222 💬
8 Soliris (eculizumab) Eculizumab 1件: D03940 💬 1件: C5 💬 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 1件: 62 💬
9 Soliris (r) - - - - 1件: 61 💬
10 Soliris - 300 mg concentrato per soluzione per infusione - uso endovenoso 1 flaconcino (vetro) 30 ml (10 mg/ml) - - - - 1件: 109 💬
11 Soliris 300 - - - - 1件: 62 💬
12 Soliris 300 mg concentrado para solución para perfusión - - - - 1件: 109 💬
13 Soliris® - - - - 1件: 62 💬